BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35760756)

  • 41. DPP8 is a novel therapeutic target for multiple myeloma.
    Sato T; Tatekoshi A; Takada K; Iyama S; Kamihara Y; Jawaid P; Rehman MU; Noguchi K; Kondo T; Kajikawa S; Arita K; Wada A; Murakami J; Arai M; Yasuda I; Dang NH; Hatano R; Iwao N; Ohnuma K; Morimoto C
    Sci Rep; 2019 Dec; 9(1):18094. PubMed ID: 31792328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo.
    Someya Y; Tahara A; Nakano R; Matsuyama-Yokono A; Nagase I; Fukunaga Y; Takasu T; Hayakawa M; Shibasaki M
    Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):209-17. PubMed ID: 18398600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity.
    Spagnuolo PA; Hurren R; Gronda M; MacLean N; Datti A; Basheer A; Lin FH; Wang X; Wrana J; Schimmer AD
    Leukemia; 2013 Jun; 27(6):1236-44. PubMed ID: 23318959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.
    Matheeussen V; Baerts L; De Meyer G; De Keulenaer G; Van der Veken P; Augustyns K; Dubois V; Scharpé S; De Meester I
    Biol Chem; 2011 Mar; 392(3):189-98. PubMed ID: 21194356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9.
    Tang HK; Chen KC; Liou GG; Cheng SC; Chien CH; Tang HY; Huang LH; Chang HP; Chou CY; Chen X
    FEBS Lett; 2011 Nov; 585(21):3409-14. PubMed ID: 22001206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.
    Zhang H; Maqsudi S; Rainczuk A; Duffield N; Lawrence J; Keane FM; Justa-Schuch D; Geiss-Friedlander R; Gorrell MD; Stephens AN
    FEBS J; 2015 Oct; 282(19):3737-57. PubMed ID: 26175140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
    Mohanty IR; Borde M; Kumar C S; Maheshwari U
    Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment.
    Janardhan S; Sastry GN
    Curr Drug Targets; 2014 Jun; 15(6):600-21. PubMed ID: 24611684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Xia C; Wang J; Su M; Zhang L; Dong T; Li Z; Wan X; Li J; Li J; Zhao L; Gao Z; Jiang H; Liu H
    Eur J Med Chem; 2014 Oct; 86():242-56. PubMed ID: 25164763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Thornberry NA; Weber AE
    Curr Top Med Chem; 2007; 7(6):557-68. PubMed ID: 17352677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors.
    Cui C; Tian X; Wei L; Wang Y; Wang K; Fu R
    Front Pharmacol; 2022; 13():1002871. PubMed ID: 36172198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice.
    Waumans Y; Vliegen G; Maes L; Rombouts M; Declerck K; Van Der Veken P; Vanden Berghe W; De Meyer GRY; Schrijvers D; De Meester I
    Inflammation; 2016 Feb; 39(1):413-424. PubMed ID: 26454447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor.
    Wu JJ; Tang HK; Yeh TK; Chen CM; Shy HS; Chu YR; Chien CH; Tsai TY; Huang YC; Huang YL; Huang CH; Tseng HY; Jiaang WT; Chao YS; Chen X
    Biochem Pharmacol; 2009 Jul; 78(2):203-10. PubMed ID: 19439267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamics of total volume of pancreatic α- and β -cells under the influence sulfonylureas and their combination with dipeptidyl peptidase-4 inhibitors.
    Taisiia Pavlovna T; Kseniia Petrovna S; Anna Anatolievna V; Ivan Sergeyevich U; Olga Vladimirovna R; Roman Viktorovich G; Alina Yurievna B; Mikhail Mikhailovich G
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00238. PubMed ID: 34277963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
    Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
    ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia.
    Johnson DC; Taabazuing CY; Okondo MC; Chui AJ; Rao SD; Brown FC; Reed C; Peguero E; de Stanchina E; Kentsis A; Bachovchin DA
    Nat Med; 2018 Aug; 24(8):1151-1156. PubMed ID: 29967349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson's disease in diabetic patients.
    Lin YH; Hsu CC; Liu JS; Chang KC; Huang JA
    Sci Rep; 2023 Dec; 13(1):22489. PubMed ID: 38110464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitors.
    Shreder KR; Wong MS; Corral S; Yu Z; Winn DT; Wu M; Hu Y; Nomanbhoy T; Alemayehu S; Fuller SR; Rosenblum JS; Kozarich JW
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4256-60. PubMed ID: 16084722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8.
    Jiaang WT; Chen YS; Hsu T; Wu SH; Chien CH; Chang CN; Chang SP; Lee SJ; Chen X
    Bioorg Med Chem Lett; 2005 Feb; 15(3):687-91. PubMed ID: 15664838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression, subcellular localisation, and possible roles of dipeptidyl peptidase 9 (DPP9) in murine macrophages.
    Zapletal E; Cupic B; Gabrilovac J
    Cell Biochem Funct; 2017 Mar; 35(2):124-137. PubMed ID: 28256001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.